Business
AstraZeneca profit jumps as cancer drug sales grow

British pharmaceutical giant AstraZeneca said Tuesday that its net profit jumped 45 percent last year on strong sales of cancer drugs, as it expands its reach in the United States and China.
Profit after tax rose to $10.2 billion in 2025 from $7.0 billion a year earlier, AstraZeneca said in a statement.
Revenue increased nine percent to $58.7 billion, boosted by a rise in cancer drug sales.
“In 2025, we saw strong commercial performance across our therapy areas and excellent pipeline delivery,” chief executive Pascal Soriot said in an earnings statement.
“The momentum across our company is continuing in 2026,” he added.
Soriot later told reporters he was “very confident” the company would achieve its target of $80 billion in annual revenue by the end of the decade.
Shares in AstraZeneca rose one percent in midday London trading, bucking a decline on the top-tier FTSE 100 index.
“If AstraZeneca knocks it out of the park with its current pipeline of final-stage trials, it could stand head and shoulders above the peer group,” said Dan Coatsworth, head of markets at AJ Bell.
– China, US focus –
AstraZeneca has recently expanded its footprint into its two largest markets, the United States and China.
The group said last month that it would invest $15 billion in China through 2030 to expand its medicines manufacturing and research, as UK Prime Minister Keir Starmer made a trip to Beijing.
During the visit, it also announced a deal with Chinese group CSPC Pharmaceutical to help develop and market weight-loss injections, which have exploded in popularity in recent years.
Britain’s largest drugmaker has also been making a recent shift towards the United States, which it hopes will account for half its global revenue by 2030.
Last year, the US accounted for 43 percent of its total revenue.
Highlighting the increasing importance of the US market, AstraZeneca began listing its shares directly on the New York Stock Exchange in February to attract more investors.
It will remain headquartered in the UK and keep its primary share listing in London.
Faced with US President Donald Trump’s threats of pharmaceutical tariffs, AstraZeneca in July revealed plans to invest $50 billion by 2030 on boosting its US manufacturing and research operations.
Trump also forged a deal with AstraZeneca for significantly lower drug prices in the United States.
In exchange, the Trump administration agreed to a three-year delay on new tariffs.
The pharmaceutical industry remains a key target of Trump, with drugs tariffs imposed on other countries as he demands companies switch operations to the US.
The post AstraZeneca profit jumps as cancer drug sales grow appeared first on Vanguard News.
Business
FG increases domestic borrowing by 241%
By Elizabeth Adegbesan
As part of the Federal Government (FG) borrowing plan for the 2026 budget, the Central Bank of Nigeria, CBN, has issued Treasury Bills, TBs, to raise N5.8 trillion in the third quarter of 2026 (Q3’26).
This represents a 241 percent year-on-year (YoY) increase when compared to N1.76 trillion sold in Q3’25.
CBN disclosed this in its Nigeria Treasury Bills Issue programme for Q3’26.
Treasury Bills are short term (less than one year) debt instruments used by the apex bank to borrow money from the Nigerian public on behalf of the federal government. CBN also uses TBs to control money supply in the economy.
The TB issue programme commenced on July 1st, and ends on September 23rd, 2026. The settlement date began yesterday and ends on September 24th, 2026.
During the period, the apex bank will issue TBs worth N900 billion on 91 days tenor, N900 billion on 182 days and N4 trillion on 364 days.
A breakdown of the programme revealed that in July, the apex bank plans to issue N2 trillion worth of TBs, comprising N300 billion worth of 91 days bills, N300 billion worth of 182 days bills and N1.4 trillion worth of 364 bills.
In August, the apex bank issued N2.1 trillion worth of TBs, comprising N300 billion worth of 91 days bills, N300 billion worth of 182 days bills, and N1.5 trillion worth of 364 days bills.
In September, CBN plans to sell N1.7 trillion worth of TBs comprising N300 billion worth of 91 days bills, N300 billion worth of 182 days bills and N1.1 trillion worth of 384 days bills.
Business
EVs: Afreximbank wants Nigeria, other African countries to stop exporting Lithium
By Emma Ujah
President and Chairman of the Board of the African Export-Import Bank (Afreximbank), Dr. George Elombi, has tasked African nations to stop the export of Lithium, the main raw material used in the production of electric vehicle (EV) batteries. Nigeria is a major exporter of Lithium in Africa, though most of the quantity is illegally exported.
Speaking at the bank’s Mid-Year Media Roundtable in Abuja on Wednesday, he said that rather than exporting raw lithium, African countries should use it to manufacture EV batteries on the continent.
He also said Afreximbank has sufficient funds to finance the production of EV batteries and is ready to provide the necessary funding to any individual or organisation willing to venture into the industry.
In his words, “African mineral resources must work for Africa’s development. EVs are the future of transportation, and the use of lithium to produce EV batteries is taking centre stage in the EV industry.
“Africa must take its position in the EV industry. We have lithium. We should produce EV batteries at home. We simply have to produce them here. There is enough money in Africa to manufacture batteries in Africa.
“If you know anyone who is interested in EV battery production, bring them to me. But if you see someone looking for funding to export lithium, don’t bring them to me.”
Dr. Elombi also said African leaders and institutions must work together to ensure that African funds held outside the continent are repatriated to support the region’s development.
Some rating agencies biased against Africa
Speaking on the bank’s credit ratings, Dr. Elombi, who advocated for African rating agencies, said some global rating agencies initially dismissed Afreximbank as too small and insignificant to drive Africa’s development, while questioning the bank’s trade finance mandate.
According to him, one agency’s 2014 assessment suggested that trade finance could not serve as a foundation for development and implied that the bank’s core mandate lacked relevance.
Business
INNOVATIONS: Enactus, NSE, NCDMB, others partner

By Ebunoluwa Sessou, Cynthia Alo & Precious Enaike
In a bid to accelerate the commercialisation of homegrown engineering solutions capable of addressing Nigeria’s development challenges, Enactus Nigeria, has established a partnership with several organizations and stakeholders to nurture young engineering talents to transform innovative ideas into practical solutions for national development through the Nigerian Engineering Olympiad (NEO).
The organizations in the partnership include the Nigerian Content Development and Monitoring Board (NCDMB), the Nigerian Society of Engineers (NSE), Renaissance Africa Energy Company, First Exploration and Petroleum Development Company (First E&P).
The Olympiad was conceived to bridge the gap between engineering education and industry by transforming students’ innovations into commercially viable businesses.
Speaking at the maiden edition of the competition in Lagos recently, Country Director of Enactus Nigeria, Michael Ajayi, disclosed that 375 applications were received from 984 students across 80 tertiary institutions in Nigeria where only 30 teams qualified for the regional stage but only 12 institutions qualified for the grand finale.
At the end of the competition, students from Modibbo Adama University, Yola, Adamawa State, clinched the grand prize of N50 million and a fully furnished engineering building for their faculty with an innovation known as Ubuntu Sapphire, a community-powered rapid alert system that connects households through low-cost devices to instantly notify neighbours and emergency responders during crises.
The University of Ibadan emerged first runner-up, winning N30 million and engineering equipment worth N75 million for its faculty with Aurora Birth, a health-tech suite designed to reduce neonatal deaths resulting from birth asphyxia in low-resource settings.
The University of Jos secured third place with FarmAnchor, a solar-powered, AI-enabled device that helps smallholder farmers detect crop pests, diseases and soil deficiencies early through multispectral imaging and edge-based machine learning. The team received N20 million, alongside N50 million worth of engineering equipment for its faculty. Ajayi said Enactus Nigeria supports forward-thinking organisations in co-creating and implementing projects that respond to real community needs through data-driven solutions, sustainability principles and entrepreneurial thinking.
“We have remained steadfast in our mission to empower young people to use entrepreneurial action to solve the world’s greatest challenges, starting with those in their immediate communities,” he said.
Delivering a keynote address on behalf of the Executive Vice Chairman and Chief Executive Officer of the National Agency for Science and Engineering Infrastructure, NASENI, Mr. Khalil Suleiman Halilu, the Deputy Director of Engineering Infrastructure Department, Dr. Emmanuel Ajani, said countries that dominate the global economy are not necessarily those endowed with abundant natural resources, but those that continuously innovate, commercialise research and build technology-driven industries.
The post INNOVATIONS: Enactus, NSE, NCDMB, others partner appeared first on Vanguard News.
-
Sports2 days agoGary Neville Names Only Team That Can Stop France From Winning the 2026 World Cup
-
Sports1 day agoVAR Expert Casts Clear Verdict on Folarin Balogun Red Card vs Bosnia
-
Sports1 day agoReal Reason Serena Williams Broke Strict Rule as $50,000 Fine Decision Made
-
Sports7 hours agoFIFA Release Statement After VAR Call During Portugal 2-1 Croatia
-
Sports22 hours agoUS Icon Brad Friedel Blasts Mexico Ahead of England Match
-
Sports2 days agoRoy Keane Names the Two Teams That Will Contest the 2026 World Cup Final
-
Sports5 hours agoCroatia’s Igor Matanovic Praised For Interview After Goal v Portugal is Ruled Out
-
Sports6 hours agoPiers Morgan Slams BBC Commentators For Cristiano Ronaldo Treatment
